Kamada Ltd KMDA 深 沪
已收盘 05-08 16:00:00 美东时间
8.55
+0.290
+3.51%
华盛通- 最 高8.55
- 今 开8.53
- 成交量 3.89万股
- 最 低 8.36
- 昨 收 8.26
- 总市值 4.93亿
- 52周最高 9.10
- 市盈率 静 24.70
- 换手率 0.07%
- 52周最低 6.25
- 委 比 46.05%
- 总股本 5768.61万
- 历史最高 17.50
- 量 比 0.87
- 振 幅 2.30%
- 历史最低 2.57
- 每 手 1
- 风险率 0.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多全球超免疫球蛋白市场预计2033年突破40亿美元，SCIG疗法与高端国产化驱动行业升级
（来源：百谏方略） 超免疫球蛋白产品介绍 超免疫球蛋白（Hyperimmune Globulins）是专门的血液制品，含有高水平的针对特定病原体的抗体。这些抗体...
04-08 14:31
Kamada Ltd Earnings Call Signals Confident Growth Path
Kamada Ltd (($IL:KMDA)) has held its Q4 earnings call. Read on for the main hig...
04-03 08:21
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
Kamada Ltd. has received a tax ruling from the Israel Tax Authority regarding a cash dividend of $0.25 per share, totaling approximately $14.4 million, to be paid on April 7, 2026. Shareholders residing in countries with a tax treaty with Israel may qualify for a reduced withholding tax rate. Documentation requirements and applications must be submitted by May 9, 2026. The company has appointed IBI Trust Management as the tax agent to process the...
03-31 11:00
Kamada’s plasma center gets FDA nod, targets EMA approval next
Kamada (KMDA), a biopharmaceutical company, announced that the FDA has approved its Kamada Plasma collection center in San Antonio, TX, following a February 2026 on-site inspection. The San Antonio ce...
03-26 19:43
Kamada Says FDA Approves Kamada Plasma's Collection Center In San Antonio
San Antonio Center Cleared to Commence Commercial Sales of Normal Source PlasmaState of the Art Facility has Annual Collection Capacity of Approximately 50,000 Liters of Plasma and an Estimated Annual Revenue
03-26 19:09
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
Kamada Ltd. announced that its San Antonio, TX plasma collection center has been approved by the FDA to commence commercial sales of normal source plasma. The state-of-the-art facility, with an annual capacity of approximately 50,000 liters of plasma, is expected to contribute $8 million to $10 million in annual revenue at full capacity. The center, one of the largest for specialty plasma collection in the U.S., will also collect anti-rabies and ...
03-26 11:00
Earnings Scheduled For March 11, 2026
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
Kamada Affirms FY2026 Sales Guidance of $200.000M-$205.000M
Kamada (NASDAQ:KMDA) affirms FY2026 sales outlook from $200.000 million-$205.000 million to $200.000 million-$205.000 million.
03-11 19:04
Kamada Q4 EPS $0.06 Misses $0.08 Estimate, Sales $44.678M Miss $45.422M Estimate
Kamada (NASDAQ:KMDA) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.08 by 22.08 percent. This is a 14.29 percent decrease over earnings of $0.07 per share from the same
03-11 19:03
What's Next: Kamada's Earnings Preview
Kamada (NASDAQ:KMDA) is gearing up to announce its quarterly earnings on Wednes...
03-11 00:01
